C-reactive protein (CRP) is an acute phase protein that rises rapidly in infections and is considered a useful biomarker to guide antibiotherapy in AECOPD [16–18]; however, there was no trials comparing clinical effectiveness and cost-effectiveness of CRP-guided strategy and a fixed short course of antibiotic in AECOPD patients. Here, CRP is linked to infection.